ClinicalTrials.Veeva

Menu

Determinants of Patient Delay in Doctor Consultation in Oeso-gastric Cancers (DELOGAST)

U

University Hospital, Lille

Status

Active, not recruiting

Conditions

Oesophageal Carcinoma
Gastric Adenocarcinoma

Treatments

Other: Questionnaire

Study type

Interventional

Funder types

Other

Identifiers

NCT03246516
2015_74
2015-A01986-43 (Other Identifier)

Details and patient eligibility

About

This study evaluates the role of socioeconomic and individual factors in the onset of the first symptoms of cancer and the first consultation with a doctor (patient delay) in oeso-gastric cancer.

Full description

Reducing the time between the onset of the first symptoms of cancer and the first consultation with a doctor (patient delay) is essential to improve the vital prognosis and quality of life of patients. Recent data suggest that some sociocognitive and emotional determinants may explain patient delay from a complementary point of view. The main objective of this study is to assess whether, in oeso-gastric cancer, patient delay is linked to these sociocognitive and emotional factors, in addition to previously known factors.

We intend to include in this study 300 patients with a not yet treated oeso-gastric cancer diagnosed in one of 10 health centres in the North of France region. The collected data will be analysed to underline the differences between patients who consulted a doctor earlier versus those who consulted later with a cut off at 8 weeks.

Enrollment

258 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • age ≥ 18 years
  • oesophageal, oeso-gastric junction or gastric cancer non treated cancer
  • patient informed of his diagnosis
  • speak fluent french

Exclusion criteria

  • history of cancer
  • psychological history
  • patient under guardianship-
  • fortuitous diagnosis of cancer

Trial design

Primary purpose

Prevention

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

258 participants in 1 patient group

Questionnaire
Experimental group
Description:
Auto and hetero questionnaire
Treatment:
Other: Questionnaire

Trial contacts and locations

10

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems